PDCD1 and non-small cell lung carcinoma: In a retrospective analysis of 64 patients with advanced NSCLC (99), patients who received cryoablation in combination with anti-PD-1(nivolumab) therapy (n=32) showed significant improvement in immune function and short-term efficacy (P < 0.05).